medigraphic.com

2023, Number 2

<< Back Next >>

Rev Fac Med UNAM 2023; 66 (2)

Mucinous Carcinoma of the Breast: A Rare Histological Type with a Favorable Prognosis

Santiago SL, Porras IGD, Malfavón FM, Méndez HG

Language: Spanish
References: 21
Page: 29-37
PDF size: 336.74 Kb.


ABSTRACT

Mucinous carcinoma is a rare type of breast cancer, which represents less than 4% of all primary cancers. It usually occurs in postmenopausal patients, around the seventh decade of life. Clinically, it is characterized by the presence of a palpable nodule, rarely accompanied by other symptoms.
Imaging tools, such as mammogram and ultrasound, are essential for its diagnosis, however, in some situations the diagnosis can be underestimated due to the similar characteristics that it shares with other benign lesions. Definitive diagnosis is made by histopathology.
Regarding treatment, there is no consensus on the most appropriate, due to the low incidence of these tumors. Many authors agree that surgical intervention continues to be the best option, showing a positive impact on survival and low recurrences. This can be accompanied later by adjuvant endocrine therapies. Fortunately, the prognosis of this type of tumor is usually favorable, even survival exceeds 90% at 5 years.


REFERENCES

  1. Budzik MP, Fudalej MM, Badowska-Kozakiewicz AM.Histopathological analysis of mucinous breast cancersubtypes and comparison with invasive carcinoma of nospecial type. Sci Rep. 2021;11(1):1-9. doi:10.1038/s41598-021-85309-z

  2. Jang Y, Jung H, Kim HN, et al. Clinicopathologic characteristicsof HER2-positive pure mucinous carcinomaof the breast. J Pathol Transl Med. 2020;54(1):95-102.doi:10.4132/jptm.2019.10.24

  3. Achicanoy Puchana DM, Lasso Andrade FA, AchicanoyPuchana DF, et al. Mucinous carcinoma of the breast: Diagnosisand management of an unusually young patient.Radiol Case Reports. 2022;17(5):1445-1449. doi:10.1016/j.radcr.2022.02.011

  4. Wang PL, Zheng FY, Lu Q, et al. Imaging features of puremucinous breast carcinoma: correlation with extracellularmucus content. Clin Radiol. 2019;74(7):569.e9-569.e17.doi:10.1016/j.crad.2019.01.031

  5. Zhao X, Yang X, Gao R, Zhai L, Yang L, Yu K. HER2-positivepure mucinous breast carcinoma: A case report and literaturereview. Medicine (Baltimore). 2020;99(33):e20996.doi:10.1097/MD.0000000000020996

  6. Marrazzo E, Frusone F, Milana F, et al. Mucinous breastcancer: A narrative review of the literature and a retrospectivetertiary single-centre analysis. Breast. 2020;49:87-92.doi:10.1016/j.breast.2019.11.002

  7. Pareja F, Lee JY, Brown DN, et al. e Genomic Landscapeof Mucinous Breast Cancer. J Natl Cancer Inst.2019;111(7):737-741. doi:10.1093/jnci/djy216

  8. Gok, Mustafa;Topal U, Oz, BahadirAkgun H, Akcan AC,Sozuer EM. Comparison of Clinical Features and TreatmentResults of Mix Mucinous Carcinomas and OtherAtypical Carcinomas of the Breast. Eur J Breast Heal.2019;15(4):222-228. doi:10.5152/ejbh.2019.5032

  9. Hu T, Huang J, Fang K. Overall Survival in Patients withMucinous Carcinoma of Breast: A Population-Based Study.Int J Gen Med. 2021;Volume 14:9991-10001. doi:10.2147/ijgm.s343137

  10. Ginter PS, Tang X, Shin SJ. A review of mucinous lesionsof the breast. Breast J. 2020;26(6):1168-1178. doi:10.1111/tbj.13878

  11. Gwark S chan, Lee HS, Lee Y, et al. Clinical Implicationof HER2 Status in Hormone Receptor-Positive MucinousBreast Cancer. Ann Surg Oncol. 2019;26(7):2166-2174.doi:10.1245/s10434-019-07332-9

  12. Isozaki H, Yamamoto Y, Sakai K, et al. Mucinous carcinomaof the breast: Clinicopathological features andlong-term prognosis in comparison with invasive ductalcancer; A single hospital’s 30+-year experience. Acta MedOkayama. 2020;74(2):137-143.

  13. Nguyen B, Veys I, Leduc S, et al. Genomic, Transcriptomic,Epigenetic, and Immune Proling of Mucinous Breast Cancer.J Natl Cancer Inst. 2019;111(7):742-746. doi:10.1093/jnci/djz023

  14. Lu K, Wang X, Zhang W, et al. Clinicopathological andgenomic features of breast mucinous carcinoma. Breast.2020;53:130-137. doi:10.1016/j.breast.2020.07.010

  15. Risner V, Jordan S. Mucinous carcinoma in an octogenarian:Treatment and management of breast cancer inthe elderly. Radiol Case Reports. 2021;16(11):3201-3207.doi:10.1016/j.radcr.2021.07.077

  16. Cserni G. Histological type and typing of breast carcinomasand the WHO classication changes over time. Pathologica.2020;112(1):25-41. doi:10.32074/1591-951X-1-20

  17. Asano Y, Kashiwagi S, Nagamori M, et al. Pure MucinousBreast Carcinoma with Micropapillary Pattern (MUMPC):A Case Report. Case Rep Oncol. 2019;12(2):554-559.doi:10.1159/000501766

  18. Du P, Hou C, Tang J, et al. A Case of Pure MucinousBreast Carcinoma in a 25-Year-Old Female Who ShowedComplete Pathological Response to Neoadjuvant Chemotherapydespite Poor Clinical Response. Breast Care.2020;15(5):538-542. doi:10.1159/000504125

  19. Xiang F, Duan Y, Wang J, Xie M. Concurrent pure mucinousbreast carcinoma and osteogenesis imperfecta.Asian J Surg. 2022 Jun;45(6):1361-1362. doi:10.1016/j.asjsur.2022.02.020

  20. Baig A, Omeroglu-Altinel G, Omeroglu A. Invasive Pleomorphic-Type Lobular Carcinoma of the Breast Presentingas a Mucinous Carcinoma. Case Rep Pathol. 2019;2019:1-5.doi:10.1155/2019/1839208

  21. Sun M, Su S, Liu Q, Li Q, Wang K. Mammary synchronousmucinous cystadenocarcinoma and columnar cellmucinous carcinoma: a case report. Int J Clin Exp Pathol.2020;13(9):2381-2386.




2020     |     www.medigraphic.com